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mild and the patient responded well 
to antimicrobial drug therapy, albeit 
without catheter removal. This case 
emphasizes that environmental bacte-
ria can be an emerging threat for he-
modialysis patients, who are at risk of 
acquiring opportunistic infection. In 
addition, this report demonstrates the 
usefulness of molecular methods for 
identifying uncommon isolates.
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Mycobacterium 
cosmeticum, Ohio 
and Venezuela
To the Editor:  Mycobacterium 
cosmeticum is a rapidly growing non-
tuberculous mycobacteria species that 
was ﬁ  rst described in November 2004. 
The ﬁ  rst strains were obtained from 
cultures of a sink drain in a nail salon 
in Atlanta, Georgia, USA, and from a 
granulomatous lesion of a female me-
sotherapy patient in Venezuela (1).
Among 3 additional isolates of 
M. cosmeticum  obtained from July 
2003 through November 2004, one 
was obtained from a 77-year-old man 
who was admitted to Ohio hospital A 
on September 22, 2004, with fever, 
exacerbation of chronic obstructive 
pulmonary disease, and urosepsis. 
Underlying medical conditions in-
cluded diabetes, discitis, hyperlip-
idemia, coronary artery disease, and 
coal worker’s pneumoconiosis. He 
had received intravenous antimicro-
bial agents (rifampin and daptomycin) 
through a Groshong catheter that had 
been inserted to treat discitis. A rou-
tine blood culture was performed ac-
cording to standard methods (2), and 
the catheter was removed. A diagno-
sis of catheter-associated bacteremia 
(CAB) was made, but the patient’s 
overall condition improved without 
antibacterial drug therapy, and he was 
discharged 4 days after admission. The 
culture specimen yielded only my-
cobacteria and was sent on to ARUP 
Laboratories, where it was identiﬁ  ed 
as M. cosmeticum by 16S rDNA se-
quence analysis. The isolate was then 
sent to the Centers for Disease Control 
and Prevention (CDC) Mycobacteriol-
ogy Laboratory Branch (Atlanta, GA, 
USA) and designated OH1.
A 43-year-old woman with a diag-
nosis of non-Hodgkin lymphoma, who 
had received regular central venous 
catheterizations, was admitted to Ohio 
hospital B on August 20, 2004. A left 
subclavian catheter was inserted, and 
Table. Biochemical characteristics of patient’s isolate RB28 and type strains of Dyella
species*
Characteristics
 Patient’s isolate 
 RB28 
D. japonica
XD53
T
D. koreensis
BB4
T
Oxidase + + +
Catalase + + w 
Motility + + +
Acid from 
 L-arabinose  – – –
 D-galactose  – – –
 D-glucose  + + +
 D-mannose  + + –
 D-ribose  – – –
 D-sucrose  – – +
 D-xylose  – – –
 Caprate  – – –
 Citrate  – – –
α-galactosidase –– +
β-N-acetyl-glucosaminidase  –w  +
α-glucosidase –w  +
*Data from references (6) and (8); T, type strain. LETTERS
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a routine blood specimen for culture 
was subsequently obtained on the day 
of admission. Before admission, the 
woman had been receiving acyclovir 
and cefepime. She received chemo-
therapeutic agent injections, platelet 
infusion, and an autologous stem cell 
transplant 6 days after admission. The 
blood culture was positive only for 
rapidly growing mycobacteria, and the 
ﬁ  nal diagnosis was CAB. However, no 
symptoms of infection were observed, 
and no antimycobacterial drug therapy 
was administered. She was discharged 
without complications after the trans-
plant was received and the catheter 
removed. The bacterial isolate was 
forwarded to CDC’s Special Bacteri-
ology Reference Laboratory, where it 
was identiﬁ  ed as M. cosmeticum by 
16S rDNA sequence analysis, sent on 
to the CDC Mycobacteriology Labo-
ratory Branch, and designated OH2.
A 36-year-old man with AIDS 
was admitted to hospital C in Caracas, 
Venezuela, in June 2003 with  dys-
pnea, fever, and expectoration. A spu-
tum sample was positive by acid-fast 
bacillus smear and culture, yielding 
both M. cosmeticum (designated VZ1) 
and M. scrofulaceum on Middlebrook 
7H10 agar (Remel Co., Lenexa, KS, 
USA). At the time the sputum was ob-
tained, the patient was receiving only 
trimethoprim-sulfamethoxazole, but 
he experienced respiratory arrest and 
died ≈6 weeks later.
The 3 isolates were conﬁ  rmed 
to be M. cosmeticum by high-perfor-
mance liquid chromatography myco-
late analyses and by PCR restriction 
analysis of a 440-bp segment of hsp65 
(1). The relationship of these isolates 
to the only documented strains of M. 
cosmeticum was evaluated by analy-
sis of large restriction fragments with 
pulsed-ﬁ   eld gel electrophoresis (1) 
and by repetitive element PCR (3). 
Banding patterns for isolates OH1 and 
OH2 were different from one another 
as well as from isolate VZ1 and the 
2 control strains. Typing patterns for 
isolate VZ1, however, matched the 
control strain from Venezuela (ATCC 
BAA-878T), which indicates that these 
2 isolates are likely a common strain 
(Figure).
Of the >125 recognized Myco-
bacterium species, ≈50 are etiologic 
agents of human disease (4). The type 
strain of M. cosmeticum (ATCC BAA-
878T) was associated with a soft-tis-
sue infection in which the source was 
postulated to be environmental con-
tamination of an unknown substance 
administered to the patient by injec-
tion as part of a weight loss regimen. 
This strain and isolate VZ1 were iso-
lated from clinics in Caracas, Venezu-
ela; both were found to be a common 
strain, but no other factors suggest 
that these represent an epidemic clus-
ter. Although the Venezuelan patient 
from whom isolate VZ1 was obtained 
exhibited symptoms consistent with 
mycobacterial pulmonary disease, M. 
cosmeticum involvement cannot be 
proven because an additional Myco-
bacterium species, M. scrofulaceum, 
was isolated from the patient’s spu-
tum. Because each of these organisms 
is found in the aqueous environment, 
they may represent colonization or 
may have been transiently present in 
the patient. Nonetheless, additional 
nontuberculous mycobacteria species 
have been reported to cause pulmo-
nary disease, and the involvement of 
M. cosmeticum in this case cannot be 
excluded.
Successful treatment of CAB in-
fections caused by rapidly growing 
mycobacteria has most often been 
achieved by removing the catheter 
with or without the use of antimicro-
bial drug therapy (4). Criteria to sup-
port a true bloodstream infection were 
met by one of the patients in Ohio. 
These criteria include the absence of a 
source for bacteremia alternative to M. 
cosmeticum OH1 and the resolution of 
the febrile syndrome after removal of 
the device. The second patient had 
no symptoms when the blood culture 
was obtained; thus, the clinical signiﬁ  -
cance of M. cosmeticum in this case is 
unclear.
Figure. Repetitive element (Rep)–PCR (A) and pulsed-ﬁ  eld gel electrophoresis (PFGE) 
(B) patterns of Mycobacterium cosmeticum isolates from 2 patients in Ohio and 1 patient 
in Venezuela. Rep-PCR was performed by using BOXA1R primer (3), and PFGE was 
performed with restriction enzyme AseI. Lanes 1, 2, Ohio isolates OH1 and OH2; lanes 
3, 4, control strains ATCC BAA-878T and ATCC BAA-879; lane 5, Venezuelan isolate VZ1. 
DNA size standards are 100-bp (S1) and 48.5-kb marker (S2).LETTERS
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When all identiﬁ  ed strains of M. 
cosmeticum are considered, this spe-
cies is clearly present in diverse geo-
graphic regions and in healthcare in-
stitutions. These ﬁ  ndings suggest that 
it may be widely distributed in the 
environment and should be regarded, 
along with other rapidly growing 
mycobacteria species, as a potential 
pathogen.
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Ecoregional 
Dominance in 
Spatial Distribution 
of Avian Inﬂ  uenza 
(H5N1) Outbreaks 
To the Editor: Recent articles in 
Emerging Infectious Diseases (1,2) 
and elsewhere (3,4) have highlighted 
the role of Anatidae migration in dis-
persal of the H5N1 subtype of highly 
pathogenic avian inﬂ  uenza (HPAI) vi-
rus. Although these articles point out 
that identifying the geographic origin 
of migrating waterfowl is needed to 
understand and predict pathogen dis-
persal, study analyses have been limit-
ed to pathways with nominal reference 
to climatic and vegetation patterns that 
control spatiotemporal patterns of this 
migration.
We propose that a better under-
standing of the threat of future spread 
can be obtained by identifying speciﬁ  c 
climatic and vegetation zones that are 
important in the life cycle of Anatidae, 
and which account for a disproportion-
ately large number of HPAI outbreaks. 
The concept of ecoregions (5,6), i.e., 
distinct assemblages of natural com-
munities determined by climate, geol-
ogy, and evolution, is a useful zonal 
classiﬁ   cation for evaluating HPAI 
outbreaks. A World Wildlife Fund 
classiﬁ   cation delineating 825 terres-
trial ecoregions (7), combined with 
a Google Earth map of 3,133 avian 
inﬂ   uenza outbreaks from November 
24, 2003, to November 21, 2006 (8), 
provided the basis for this analysis. 
All ﬁ  les were converted to shapeﬁ  les 
(Environmental Systems Research 
Institute, Redlands, CA, USA), and 
overlay analysis was performed by us-
ing ArcGIS software (Environmental 
Systems Research Institute).
The online Appendix Figure 
(available from www.cdc.gov/EID/
content/13/8/1269-appG.htm) shows 
a chloropleth map (display of quanti-
tative or qualitative information about 
subentities in terms of symbols or 
colors) of ecoregions with numbers 
of avian inﬂ   uenza cases (each spa-
tially and temporally isolated set of 
individual events, regardless of num-
ber of deaths, is recorded as a case). 
Panels A, B, and C of this ﬁ  gure show 
enlargements of speciﬁ  c  ecoregions 
with large numbers of known cases 
in regions of Eurasia, Southeast Asia, 
and Africa, respectively. Twenty-ﬁ  ve 
ecoregions, representing 8.8% of the 
terrestrial surface area, accounted for 
2,407 (76.8%) cases. A total of 132 of 
825 ecoregional classiﬁ  cations had >1 
recorded case of an avian inﬂ  uenza 
outbreak, but most (83) had <10 cases 
each.
Regionally, Southeast Asia has 12 
ecoregions that collectively account 
for 1,651 cases (online Appendix Fig-
ure, panel B) that have occurred con-
sistently, albeit cyclically, since 2003. 
Among these ecoregions, the fresh-
water wetlands of the Chao Phraya, 
Tonle Sap, and Red Rivers are known 
migratory waterfowl wintering habi-
tats in which 719 cases were located. 
Recent phylogenetic evidence sug-
gests that this area is a local hotspot 
for an endemic strain of avian inﬂ  u-
enza (H5N1) that demonstrates bidi-
rectional dispersal among localities 
within the region (9).
In the Eurasian region (online 
Appendix Figure, panel A), 12 ecore-
gions accounted for 712 cases. The 
easternmost ecoregions, the Kazakh 
forest steppe (location of Lake Chany, 
an Anatidae habitat and breeding area) 
and the Kazakh Steppe, accounted for 
132 cases, with the ﬁ  rst case recorded 